Home > > > > > Report Detail

Global Duchenne Muscular Dystrophy Drugs Market Growth (Status and Outlook) 2023-2029

Publisher Name :
Date: 06-Feb-2023
No. of pages: 104

LPI (LP Information)' newest research report, the "Duchenne Muscular Dystrophy Drugs Industry Forecast" looks at past sales and reviews total world Duchenne Muscular Dystrophy Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Duchenne Muscular Dystrophy Drugs sales for 2023 through 2029. With Duchenne Muscular Dystrophy Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Duchenne Muscular Dystrophy Drugs industry.

This Insight Report provides a comprehensive analysis of the global Duchenne Muscular Dystrophy Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Duchenne Muscular Dystrophy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Duchenne Muscular Dystrophy Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Duchenne Muscular Dystrophy Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Duchenne Muscular Dystrophy Drugs.

The global Duchenne Muscular Dystrophy Drugs market size is projected to grow from US$ 989.8 million in 2022 to US$ 8185.6 million in 2029; it is expected to grow at a CAGR of 35.2% from 2023 to 2029.

United States market for Duchenne Muscular Dystrophy Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Duchenne Muscular Dystrophy Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Duchenne Muscular Dystrophy Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Duchenne Muscular Dystrophy Drugs players cover Biogen, Roche, Daiichi Sankyo, Pfizer, Cumberland Pharmaceuticals, Santhera Pharmaceuticals, Taiho Pharmaceutical, Teijin Pharma and Akashi Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Duchenne Muscular Dystrophy Drugs market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

- Molecular-based Therapies

- Steroid Therapy

- Other

Segmentation by application

- Hospitals

- Clinics

- Others

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

- Biogen

- Roche

- Daiichi Sankyo

- Pfizer

- Cumberland Pharmaceuticals

- Santhera Pharmaceuticals

- Taiho Pharmaceutical

- Teijin Pharma

- Akashi Therapeutics

- Sarepta Therapeutics

- BioMarin

- Fibrogen Inc

- Nobelpharma Co. Ltd

- Eloxx Pharmaceuticals

Global Duchenne Muscular Dystrophy Drugs Market Growth (Status and Outlook) 2023-2029

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Duchenne Muscular Dystrophy Drugs Market Size 2018-2029
2.1.2 Duchenne Muscular Dystrophy Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Duchenne Muscular Dystrophy Drugs Segment by Type
2.2.1 Molecular-based Therapies
2.2.2 Steroid Therapy
2.2.3 Other
2.3 Duchenne Muscular Dystrophy Drugs Market Size by Type
2.3.1 Duchenne Muscular Dystrophy Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Duchenne Muscular Dystrophy Drugs Market Size Market Share by Type (2018-2023)
2.4 Duchenne Muscular Dystrophy Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Duchenne Muscular Dystrophy Drugs Market Size by Application
2.5.1 Duchenne Muscular Dystrophy Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Duchenne Muscular Dystrophy Drugs Market Size Market Share by Application (2018-2023)
3 Duchenne Muscular Dystrophy Drugs Market Size by Player
3.1 Duchenne Muscular Dystrophy Drugs Market Size Market Share by Players
3.1.1 Global Duchenne Muscular Dystrophy Drugs Revenue by Players (2018-2023)
3.1.2 Global Duchenne Muscular Dystrophy Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Duchenne Muscular Dystrophy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Duchenne Muscular Dystrophy Drugs by Regions
4.1 Duchenne Muscular Dystrophy Drugs Market Size by Regions (2018-2023)
4.2 Americas Duchenne Muscular Dystrophy Drugs Market Size Growth (2018-2023)
4.3 APAC Duchenne Muscular Dystrophy Drugs Market Size Growth (2018-2023)
4.4 Europe Duchenne Muscular Dystrophy Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size Growth (2018-2023)
5 Americas
5.1 Americas Duchenne Muscular Dystrophy Drugs Market Size by Country (2018-2023)
5.2 Americas Duchenne Muscular Dystrophy Drugs Market Size by Type (2018-2023)
5.3 Americas Duchenne Muscular Dystrophy Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Duchenne Muscular Dystrophy Drugs Market Size by Region (2018-2023)
6.2 APAC Duchenne Muscular Dystrophy Drugs Market Size by Type (2018-2023)
6.3 APAC Duchenne Muscular Dystrophy Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Duchenne Muscular Dystrophy Drugs by Country (2018-2023)
7.2 Europe Duchenne Muscular Dystrophy Drugs Market Size by Type (2018-2023)
7.3 Europe Duchenne Muscular Dystrophy Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Duchenne Muscular Dystrophy Drugs by Region (2018-2023)
8.2 Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Duchenne Muscular Dystrophy Drugs Market Forecast
10.1 Global Duchenne Muscular Dystrophy Drugs Forecast by Regions (2024-2029)
10.1.1 Global Duchenne Muscular Dystrophy Drugs Forecast by Regions (2024-2029)
10.1.2 Americas Duchenne Muscular Dystrophy Drugs Forecast
10.1.3 APAC Duchenne Muscular Dystrophy Drugs Forecast
10.1.4 Europe Duchenne Muscular Dystrophy Drugs Forecast
10.1.5 Middle East & Africa Duchenne Muscular Dystrophy Drugs Forecast
10.2 Americas Duchenne Muscular Dystrophy Drugs Forecast by Country (2024-2029)
10.2.1 United States Duchenne Muscular Dystrophy Drugs Market Forecast
10.2.2 Canada Duchenne Muscular Dystrophy Drugs Market Forecast
10.2.3 Mexico Duchenne Muscular Dystrophy Drugs Market Forecast
10.2.4 Brazil Duchenne Muscular Dystrophy Drugs Market Forecast
10.3 APAC Duchenne Muscular Dystrophy Drugs Forecast by Region (2024-2029)
10.3.1 China Duchenne Muscular Dystrophy Drugs Market Forecast
10.3.2 Japan Duchenne Muscular Dystrophy Drugs Market Forecast
10.3.3 Korea Duchenne Muscular Dystrophy Drugs Market Forecast
10.3.4 Southeast Asia Duchenne Muscular Dystrophy Drugs Market Forecast
10.3.5 India Duchenne Muscular Dystrophy Drugs Market Forecast
10.3.6 Australia Duchenne Muscular Dystrophy Drugs Market Forecast
10.4 Europe Duchenne Muscular Dystrophy Drugs Forecast by Country (2024-2029)
10.4.1 Germany Duchenne Muscular Dystrophy Drugs Market Forecast
10.4.2 France Duchenne Muscular Dystrophy Drugs Market Forecast
10.4.3 UK Duchenne Muscular Dystrophy Drugs Market Forecast
10.4.4 Italy Duchenne Muscular Dystrophy Drugs Market Forecast
10.4.5 Russia Duchenne Muscular Dystrophy Drugs Market Forecast
10.5 Middle East & Africa Duchenne Muscular Dystrophy Drugs Forecast by Region (2024-2029)
10.5.1 Egypt Duchenne Muscular Dystrophy Drugs Market Forecast
10.5.2 South Africa Duchenne Muscular Dystrophy Drugs Market Forecast
10.5.3 Israel Duchenne Muscular Dystrophy Drugs Market Forecast
10.5.4 Turkey Duchenne Muscular Dystrophy Drugs Market Forecast
10.5.5 GCC Countries Duchenne Muscular Dystrophy Drugs Market Forecast
10.6 Global Duchenne Muscular Dystrophy Drugs Forecast by Type (2024-2029)
10.7 Global Duchenne Muscular Dystrophy Drugs Forecast by Application (2024-2029)

11 Key Players Analysis
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Duchenne Muscular Dystrophy Drugs Product Offered
11.1.3 Biogen Duchenne Muscular Dystrophy Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Duchenne Muscular Dystrophy Drugs Product Offered
11.2.3 Roche Duchenne Muscular Dystrophy Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Daiichi Sankyo
11.3.1 Daiichi Sankyo Company Information
11.3.2 Daiichi Sankyo Duchenne Muscular Dystrophy Drugs Product Offered
11.3.3 Daiichi Sankyo Duchenne Muscular Dystrophy Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Daiichi Sankyo Main Business Overview
11.3.5 Daiichi Sankyo Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Duchenne Muscular Dystrophy Drugs Product Offered
11.4.3 Pfizer Duchenne Muscular Dystrophy Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Cumberland Pharmaceuticals
11.5.1 Cumberland Pharmaceuticals Company Information
11.5.2 Cumberland Pharmaceuticals Duchenne Muscular Dystrophy Drugs Product Offered
11.5.3 Cumberland Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Cumberland Pharmaceuticals Main Business Overview
11.5.5 Cumberland Pharmaceuticals Latest Developments
11.6 Santhera Pharmaceuticals
11.6.1 Santhera Pharmaceuticals Company Information
11.6.2 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Product Offered
11.6.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Santhera Pharmaceuticals Main Business Overview
11.6.5 Santhera Pharmaceuticals Latest Developments
11.7 Taiho Pharmaceutical
11.7.1 Taiho Pharmaceutical Company Information
11.7.2 Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Product Offered
11.7.3 Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Taiho Pharmaceutical Main Business Overview
11.7.5 Taiho Pharmaceutical Latest Developments
11.8 Teijin Pharma
11.8.1 Teijin Pharma Company Information
11.8.2 Teijin Pharma Duchenne Muscular Dystrophy Drugs Product Offered
11.8.3 Teijin Pharma Duchenne Muscular Dystrophy Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Teijin Pharma Main Business Overview
11.8.5 Teijin Pharma Latest Developments
11.9 Akashi Therapeutics
11.9.1 Akashi Therapeutics Company Information
11.9.2 Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Product Offered
11.9.3 Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Akashi Therapeutics Main Business Overview
11.9.5 Akashi Therapeutics Latest Developments
11.10 Sarepta Therapeutics
11.10.1 Sarepta Therapeutics Company Information
11.10.2 Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Product Offered
11.10.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sarepta Therapeutics Main Business Overview
11.10.5 Sarepta Therapeutics Latest Developments
11.11 BioMarin
11.11.1 BioMarin Company Information
11.11.2 BioMarin Duchenne Muscular Dystrophy Drugs Product Offered
11.11.3 BioMarin Duchenne Muscular Dystrophy Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 BioMarin Main Business Overview
11.11.5 BioMarin Latest Developments
11.12 Fibrogen Inc
11.12.1 Fibrogen Inc Company Information
11.12.2 Fibrogen Inc Duchenne Muscular Dystrophy Drugs Product Offered
11.12.3 Fibrogen Inc Duchenne Muscular Dystrophy Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Fibrogen Inc Main Business Overview
11.12.5 Fibrogen Inc Latest Developments
11.13 Nobelpharma Co. Ltd
11.13.1 Nobelpharma Co. Ltd Company Information
11.13.2 Nobelpharma Co. Ltd Duchenne Muscular Dystrophy Drugs Product Offered
11.13.3 Nobelpharma Co. Ltd Duchenne Muscular Dystrophy Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Nobelpharma Co. Ltd Main Business Overview
11.13.5 Nobelpharma Co. Ltd Latest Developments
11.14 Eloxx Pharmaceuticals
11.14.1 Eloxx Pharmaceuticals Company Information
11.14.2 Eloxx Pharmaceuticals Duchenne Muscular Dystrophy Drugs Product Offered
11.14.3 Eloxx Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Eloxx Pharmaceuticals Main Business Overview
11.14.5 Eloxx Pharmaceuticals Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Duchenne Muscular Dystrophy Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Molecular-based Therapies
Table 3. Major Players of Steroid Therapy
Table 4. Major Players of Other
Table 5. Duchenne Muscular Dystrophy Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Duchenne Muscular Dystrophy Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Duchenne Muscular Dystrophy Drugs Market Size Market Share by Type (2018-2023)
Table 8. Duchenne Muscular Dystrophy Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Duchenne Muscular Dystrophy Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Duchenne Muscular Dystrophy Drugs Market Size Market Share by Application (2018-2023)
Table 11. Global Duchenne Muscular Dystrophy Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Duchenne Muscular Dystrophy Drugs Revenue Market Share by Player (2018-2023)
Table 13. Duchenne Muscular Dystrophy Drugs Key Players Head office and Products Offered
Table 14. Duchenne Muscular Dystrophy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Duchenne Muscular Dystrophy Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Duchenne Muscular Dystrophy Drugs Market Size Market Share by Regions (2018-2023)
Table 19. Global Duchenne Muscular Dystrophy Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Duchenne Muscular Dystrophy Drugs Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Duchenne Muscular Dystrophy Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Duchenne Muscular Dystrophy Drugs Market Size Market Share by Country (2018-2023)
Table 23. Americas Duchenne Muscular Dystrophy Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Duchenne Muscular Dystrophy Drugs Market Size Market Share by Type (2018-2023)
Table 25. Americas Duchenne Muscular Dystrophy Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Duchenne Muscular Dystrophy Drugs Market Size Market Share by Application (2018-2023)
Table 27. APAC Duchenne Muscular Dystrophy Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Duchenne Muscular Dystrophy Drugs Market Size Market Share by Region (2018-2023)
Table 29. APAC Duchenne Muscular Dystrophy Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Duchenne Muscular Dystrophy Drugs Market Size Market Share by Type (2018-2023)
Table 31. APAC Duchenne Muscular Dystrophy Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Duchenne Muscular Dystrophy Drugs Market Size Market Share by Application (2018-2023)
Table 33. Europe Duchenne Muscular Dystrophy Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Duchenne Muscular Dystrophy Drugs Market Size Market Share by Country (2018-2023)
Table 35. Europe Duchenne Muscular Dystrophy Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Duchenne Muscular Dystrophy Drugs Market Size Market Share by Type (2018-2023)
Table 37. Europe Duchenne Muscular Dystrophy Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Duchenne Muscular Dystrophy Drugs Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Duchenne Muscular Dystrophy Drugs
Table 46. Key Market Challenges & Risks of Duchenne Muscular Dystrophy Drugs
Table 47. Key Industry Trends of Duchenne Muscular Dystrophy Drugs
Table 48. Global Duchenne Muscular Dystrophy Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Duchenne Muscular Dystrophy Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Duchenne Muscular Dystrophy Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Duchenne Muscular Dystrophy Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Biogen Details, Company Type, Duchenne Muscular Dystrophy Drugs Area Served and Its Competitors
Table 53. Biogen Duchenne Muscular Dystrophy Drugs Product Offered
Table 54. Biogen Duchenne Muscular Dystrophy Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Biogen Main Business
Table 56. Biogen Latest Developments
Table 57. Roche Details, Company Type, Duchenne Muscular Dystrophy Drugs Area Served and Its Competitors
Table 58. Roche Duchenne Muscular Dystrophy Drugs Product Offered
Table 59. Roche Main Business
Table 60. Roche Duchenne Muscular Dystrophy Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Roche Latest Developments
Table 62. Daiichi Sankyo Details, Company Type, Duchenne Muscular Dystrophy Drugs Area Served and Its Competitors
Table 63. Daiichi Sankyo Duchenne Muscular Dystrophy Drugs Product Offered
Table 64. Daiichi Sankyo Main Business
Table 65. Daiichi Sankyo Duchenne Muscular Dystrophy Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Daiichi Sankyo Latest Developments
Table 67. Pfizer Details, Company Type, Duchenne Muscular Dystrophy Drugs Area Served and Its Competitors
Table 68. Pfizer Duchenne Muscular Dystrophy Drugs Product Offered
Table 69. Pfizer Main Business
Table 70. Pfizer Duchenne Muscular Dystrophy Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer Latest Developments
Table 72. Cumberland Pharmaceuticals Details, Company Type, Duchenne Muscular Dystrophy Drugs Area Served and Its Competitors
Table 73. Cumberland Pharmaceuticals Duchenne Muscular Dystrophy Drugs Product Offered
Table 74. Cumberland Pharmaceuticals Main Business
Table 75. Cumberland Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Cumberland Pharmaceuticals Latest Developments
Table 77. Santhera Pharmaceuticals Details, Company Type, Duchenne Muscular Dystrophy Drugs Area Served and Its Competitors
Table 78. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Product Offered
Table 79. Santhera Pharmaceuticals Main Business
Table 80. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Santhera Pharmaceuticals Latest Developments
Table 82. Taiho Pharmaceutical Details, Company Type, Duchenne Muscular Dystrophy Drugs Area Served and Its Competitors
Table 83. Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Product Offered
Table 84. Taiho Pharmaceutical Main Business
Table 85. Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Taiho Pharmaceutical Latest Developments
Table 87. Teijin Pharma Details, Company Type, Duchenne Muscular Dystrophy Drugs Area Served and Its Competitors
Table 88. Teijin Pharma Duchenne Muscular Dystrophy Drugs Product Offered
Table 89. Teijin Pharma Main Business
Table 90. Teijin Pharma Duchenne Muscular Dystrophy Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Teijin Pharma Latest Developments
Table 92. Akashi Therapeutics Details, Company Type, Duchenne Muscular Dystrophy Drugs Area Served and Its Competitors
Table 93. Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Product Offered
Table 94. Akashi Therapeutics Main Business
Table 95. Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Akashi Therapeutics Latest Developments
Table 97. Sarepta Therapeutics Details, Company Type, Duchenne Muscular Dystrophy Drugs Area Served and Its Competitors
Table 98. Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Product Offered
Table 99. Sarepta Therapeutics Main Business
Table 100. Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Sarepta Therapeutics Latest Developments
Table 102. BioMarin Details, Company Type, Duchenne Muscular Dystrophy Drugs Area Served and Its Competitors
Table 103. BioMarin Duchenne Muscular Dystrophy Drugs Product Offered
Table 104. BioMarin Duchenne Muscular Dystrophy Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. BioMarin Main Business
Table 106. BioMarin Latest Developments
Table 107. Fibrogen Inc Details, Company Type, Duchenne Muscular Dystrophy Drugs Area Served and Its Competitors
Table 108. Fibrogen Inc Duchenne Muscular Dystrophy Drugs Product Offered
Table 109. Fibrogen Inc Main Business
Table 110. Fibrogen Inc Duchenne Muscular Dystrophy Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Fibrogen Inc Latest Developments
Table 112. Nobelpharma Co. Ltd Details, Company Type, Duchenne Muscular Dystrophy Drugs Area Served and Its Competitors
Table 113. Nobelpharma Co. Ltd Duchenne Muscular Dystrophy Drugs Product Offered
Table 114. Nobelpharma Co. Ltd Main Business
Table 115. Nobelpharma Co. Ltd Duchenne Muscular Dystrophy Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Nobelpharma Co. Ltd Latest Developments
Table 117. Eloxx Pharmaceuticals Details, Company Type, Duchenne Muscular Dystrophy Drugs Area Served and Its Competitors
Table 118. Eloxx Pharmaceuticals Duchenne Muscular Dystrophy Drugs Product Offered
Table 119. Eloxx Pharmaceuticals Main Business
Table 120. Eloxx Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Eloxx Pharmaceuticals Latest Developments
List of Figures
Figure 1. Duchenne Muscular Dystrophy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Duchenne Muscular Dystrophy Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Duchenne Muscular Dystrophy Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Duchenne Muscular Dystrophy Drugs Sales Market Share by Country/Region (2022)
Figure 8. Duchenne Muscular Dystrophy Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Duchenne Muscular Dystrophy Drugs Market Size Market Share by Type in 2022
Figure 10. Duchenne Muscular Dystrophy Drugs in Hospitals
Figure 11. Global Duchenne Muscular Dystrophy Drugs Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Duchenne Muscular Dystrophy Drugs in Clinics
Figure 13. Global Duchenne Muscular Dystrophy Drugs Market: Clinics (2018-2023) & ($ Millions)
Figure 14. Duchenne Muscular Dystrophy Drugs in Others
Figure 15. Global Duchenne Muscular Dystrophy Drugs Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Duchenne Muscular Dystrophy Drugs Market Size Market Share by Application in 2022
Figure 17. Global Duchenne Muscular Dystrophy Drugs Revenue Market Share by Player in 2022
Figure 18. Global Duchenne Muscular Dystrophy Drugs Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Duchenne Muscular Dystrophy Drugs Market Size 2018-2023 ($ Millions)
Figure 20. APAC Duchenne Muscular Dystrophy Drugs Market Size 2018-2023 ($ Millions)
Figure 21. Europe Duchenne Muscular Dystrophy Drugs Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size 2018-2023 ($ Millions)
Figure 23. Americas Duchenne Muscular Dystrophy Drugs Value Market Share by Country in 2022
Figure 24. United States Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Duchenne Muscular Dystrophy Drugs Market Size Market Share by Region in 2022
Figure 29. APAC Duchenne Muscular Dystrophy Drugs Market Size Market Share by Type in 2022
Figure 30. APAC Duchenne Muscular Dystrophy Drugs Market Size Market Share by Application in 2022
Figure 31. China Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Duchenne Muscular Dystrophy Drugs Market Size Market Share by Country in 2022
Figure 38. Europe Duchenne Muscular Dystrophy Drugs Market Size Market Share by Type (2018-2023)
Figure 39. Europe Duchenne Muscular Dystrophy Drugs Market Size Market Share by Application (2018-2023)
Figure 40. Germany Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Duchenne Muscular Dystrophy Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 54. APAC Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 55. Europe Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 57. United States Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 58. Canada Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 61. China Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Japan Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 63. Korea Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 65. India Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 66. Australia Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 67. Germany Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 68. France Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 69. UK Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Italy Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Russia Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 72. Spain Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 75. Israel Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Duchenne Muscular Dystrophy Drugs Market Size 2024-2029 ($ Millions)
Figure 78. Global Duchenne Muscular Dystrophy Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Duchenne Muscular Dystrophy Drugs Market Size Market Share Forecast by Application (2024-2029)
  • Global Testosterone Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113
    According to our LPI (LP Information) latest study, the global Testosterone Replacement Therapy market size was valued at US$ 1493.3 million in 2023. With growing demand in downstream market, the Testosterone Replacement Therapy is forecast to a readjusted size of US$ 1101.6 million by 2030 with a CAGR of -4.3% during review period. The research report highlights the growth potential of the global Testosterone Replacement Therapy market. Testosterone Replacement Therapy are expected to s......
  • Global Finasteride Tablets Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The Finasteride Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Finasteride Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Global Erectile Dysfunction Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Erectile Dysfunction Drugs market size was valued at US$ 4749.4 million in 2023. With growing demand in downstream market, the Erectile Dysfunction Drugs is forecast to a readjusted size of US$ 7247.8 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Erectile Dysfunction Drugs market. Erectile Dysfunction Drugs are expected to show stable growth in the ......
  • Global Methyltestosterone Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 75
    The Methyltestosterone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methyltestosterone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles......
  • Global Tamsulosin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Tamsulosin market: According to our latest research, the global Tamsulosin market looks promising in the next 5 years. As of 2022, the global Tamsulosin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Tamsulosin market, with a systematical de......
  • Global Erectile Dysfunction Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Erectile Dysfunction Drug market: According to our latest research, the global Erectile Dysfunction Drug market looks promising in the next 5 years. As of 2022, the global Erectile Dysfunction Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Finasteride Tablets Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 98
    Market Overview of Global Finasteride Tablets market: According to our latest research, the global Finasteride Tablets market looks promising in the next 5 years. As of 2022, the global Finasteride Tablets market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Finasteride Ta......
  • Finasteride Tablets - Global Market Insights and Sales Trends 2024
    Published: 19-Dec-2023        Price: US 3350 Onwards        Pages: 106
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Finasteride Tablets, with both quantit......
  • Global Duchenne Muscular Dystrophy Drugs Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 134
    Report Overview: The Global Duchenne Muscular Dystrophy Drugs Market Size was estimated at USD 8086.70 million in 2022 and is projected to reach USD 62734.28 million by 2029, exhibiting a CAGR of 34.00% during the forecast period. This report provides a deep insight into the global Duchenne Muscular Dystrophy Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs